BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7266716)

  • 1. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits.
    Cavallo T; Johnson MP
    Nephron; 1981; 27(6):281-4. PubMed ID: 7266716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.
    Pardo V; Riesgo I; Zilleruelo G; Strauss J
    Am J Kidney Dis; 1984 Jan; 3(4):264-9. PubMed ID: 6691342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
    Trachtman H; Laskowski J; Lee C; Renner B; Feemster A; Parikh S; Panzer SE; Zhong W; Cravedi P; Cantarelli C; Kulik L; You Z; Satchell S; Rovin B; Liu F; Kalled SL; Holers VM; Jalal D; Thurman JM
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F505-F516. PubMed ID: 34459222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
    Hsu HC; Chen WY; Lin GJ; Chen L; Kao SL; Huang CC; Lin CY
    Histopathology; 1984 May; 8(3):435-46. PubMed ID: 6376323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome.
    Ji-Yun Y; Melvin T; Sibley R; Michael AF
    Kidney Int; 1984 Jan; 25(1):100-6. PubMed ID: 6727121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
    Looi LM; Wang F; Lam KL; Chua CT
    Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
    Swartz SJ; Eldin KW; Hicks MJ; Feig DI
    Pediatr Nephrol; 2009 Jun; 24(6):1187-92. PubMed ID: 19219463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE in patients with glomerulonephritis and minimal-change nephrotic syndrome.
    Schulte-Wissermann H; Görtz W; Straub E
    Eur J Pediatr; 1979 May; 131(2):105-11. PubMed ID: 378666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of IgM mesangial deposits in the nephrotic syndrome.
    Gonzalo A; Mampaso F; Gallego N; Quereda C; Fierro C; Ortuño J
    Nephron; 1985; 41(3):246-9. PubMed ID: 4058625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-morphologic heterogeneity of minimal changes in glomerulonephritis].
    Shestakova LA; Varshavskiĭ VA
    Arkh Patol; 1994; 56(6):22-8. PubMed ID: 7605213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM nephropathy: morphological study related to clinical findings.
    Kopolovic J; Shvil Y; Pomeranz A; Ron N; Rubinger D; Oren R
    Am J Nephrol; 1987; 7(4):275-80. PubMed ID: 3318460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
    Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
    Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimal change nephrotic syndrome with predominant mesangial IgA deposits: clinicopathological study].
    Soma J; Saito T; Sato H; Ootaka T; Suzuki M; Chiba S; Taguma Y; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):153-9. PubMed ID: 2051642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of mesangial IgM deposition in "minimal change" nephrotic syndrome.
    Vilches AR; Turner DR; Cameron JS; Ogg CS; Chantler C; Williams DG
    Lab Invest; 1982 Jan; 46(1):10-5. PubMed ID: 7054586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?
    Brugnano R; Del Sordo R; Covarelli C; Gnappi E; Pasquali S
    J Nephrol; 2016 Aug; 29(4):479-86. PubMed ID: 26842624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrotic syndrome in a child, with minimal glomerular lesions and mesangial IgA deposits].
    Saint-André JP; Simard C; Spiesser R; Houssin A
    Nouv Presse Med; 1980 Feb; 9(8):531-2. PubMed ID: 7367286
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
    Choi J; Jeong HJ; Lee HY; Kim PK; Lee JS; Han DS
    Yonsei Med J; 1990 Sep; 31(3):258-63. PubMed ID: 2281685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions.
    Hirszel P; Yamase HT; Carney WR; Galen MA; Graeber CW; Johnson KJ; Kennedy TL; Lapkin RA; McLean RH; Rosenworcel E
    Nephron; 1984; 38(2):100-8. PubMed ID: 6382035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of glomerular minimal lesion and minimal mesangial proliferation with or without nephrotic syndrome; pathologic, immunopathologic and clinical correlations.
    Choi IJ; Jeong HJ; Kim PK; Lee JS; Kim KS; Lee HY; Chung SH; Kim DS
    Yonsei Med J; 1986; 27(1):17-24. PubMed ID: 3300054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.